American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
复制标题

DOI:
10.1002/acr.21664
复制
发表时间:
2012-06
影响因子:
4.7
通讯作者:
Grossman, Jennifer M.
Grossman, Jennifer M.
中科院分区:
医学2区
文献类型:
--
作者:
Hahn, Bevra H.;McMahon, Maureen A.;Wilkinson, Alan;Wallace, W. Dean;Daikh, David I.;Fitzgerald, John D.;Karpouzas, George A.;Merrill, Joan T.;Wallace, Daniel J.;Yazdany, Jinoos;Ramsey-Goldman, Rosalind;Singh, Karandeep;Khalighi, Mazdak;Choi, Soo-In;Gogia, Maneesh;Kafaja, Suzanne;Kamgar, Mohammad;Lau, Christine;Martin, William J.;Parikh, Sefali;Peng, Justin;Rastogi, Anjay;Chen, Weiling;Grossman, Jennifer M.

文献摘要

参考文献

被引文献

相似文献

在美国,大约35%的系统性红斑狼疮(SLE)成人在诊断时有肾炎的临床证据,估计总共有50-60%在疾病的前10年内发展为肾炎(1-4)。肾炎的患病率在非洲裔美国人和西班牙裔美国人中明显高于白人,男性高于女性。肾损害是
In the US, approximately 35% of adults with systemic lupus erythematosus (SLE) have clinical evidence of nephritis at the time of diagnosis, with an estimated total of 50–60% developing nephritis during the first 10 years of disease (1–4). The prevalence of nephritis is significantly higher in African Americans and Hispanics than in whites, and is higher in men than in women. Renal damage is
DOI: 10.1002/art.22159
发表时间: 2006-11-01
影响因子: --
作者:
Clowse, Megan E. B.;Magder, Laurence;Petri, Michelle
通讯作者: Petri, Michelle
DOI: 10.1016/j.berh.2004.02.012
发表时间: 2004-06-01
影响因子: 5.2
作者:
Gordon, C
通讯作者: Gordon, C
DOI: 10.7326/0003-4819-125-7-199610010-00003
发表时间: 1996-10-01
影响因子: 39.2
作者:
Gourley, MF;Austin, HA;Steinberg, AD
通讯作者: Steinberg, AD
DOI: 10.1002/art.22449
发表时间: 2007-02-01
影响因子: --
作者:
Grootscholten, Cecile;Bajema, Ingeborg M.;Berden, Jo H. M.
通讯作者: Berden, Jo H. M.
DOI: 10.1681/asn.2008101028
发表时间: 2009-05-01
影响因子: 13.6
作者:
Appel, Gerald B.;Contreras, Gabriel;Wofsy, David
通讯作者: Wofsy, David